Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REDUCTION: Culture-Directed vs Empiric Antibiotics for UTI
NCT05726318Phase 4Completed
- Start
- Feb 2023
- Primary completion
- Aug 2024
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in urinary tract infection (UTI). Primary endpoint: Eligible Subjects That Were Enrolled in the Study at 17.5 months. Started Feb 2023; status: completed.
02
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT05726318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05726318.